Leqembi & Kisunla: Extending Independent Living
February 16, 2025
A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.
Search Results for: leqembi – Page 3
Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses
February 3, 2025
The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more
Is Leqembi Shrinking the Alzheimer’s or the Brain?
January 5, 2025
Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light
Catching Up to America: Europe Recommends Leqembi® for Alzheimer’s
November 17, 2024
The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.
Leqembi Autoinjector to Treat Alzheimer’s in Seconds, Not Hours
November 3, 2024
Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.
3 Questions on Leqembi & Kisunla, the New Alzheimer’s Drugs
October 21, 2024
The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe
July 26, 2024
While the initial headlines might seem discouraging, there’s always more to the story. 🌟
How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs
July 14, 2024
The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
Leqembi Launched in China to Fight Alzheimer’s
July 3, 2024
China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.
Making it Easier to Take Leqembi for Alzheimer’s
June 23, 2024
A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.